Cargando…
Comorbidity Associations with AATD Among Commercially Insured and Medicare Beneficiaries with COPD in the US
INTRODUCTION: Alpha-1 antitrypsin deficiency (AATD) is often not identified in patients with chronic obstructive pulmonary disease (COPD) until advanced stages of disease, despite the availability of genetic testing. While clinical practice guidelines provide recommendations on patients who should b...
Autores principales: | Sandhaus, Robert, Strange, Charlie, Stone, Glenda, Runken, M Chris, Blanchette, Christopher M, Howden, Reuben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547287/ https://www.ncbi.nlm.nih.gov/pubmed/33116454 http://dx.doi.org/10.2147/COPD.S263297 |
Ejemplares similares
-
AATD
por: Hood, E
Publicado: (2002) -
Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer
por: Shah, Shweta, et al.
Publicado: (2019) -
Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population
por: Kern, David M, et al.
Publicado: (2015) -
Patterns of Comorbidity and Multimorbidity Among Patients With Multiple Sclerosis in a Large US Commercially Insured and Medicare Advantage Population
por: Dai, Dingwei, et al.
Publicado: (2022) -
HEALTHCARE EXPERIENCES OF NHOPI AND OTHER U.S. ASIAN MEDICARE BENEFICIARIES
por: Beckett, Megan K, et al.
Publicado: (2019)